An in vitro study by Wang and colleagues determined that RSG attenuated the BPA-induced increase in APP, beta-site APP cleaving enzyme 1 (BACE1), and Aβ1-42, all of which are key proteins involved in the pathogenesis of AD [101]. This evidence concerns the gene BACE1 and Alzheimer disease.